Clinical trial shows FDA-approved antihistamine restores nervous system function in MS patients.
UCSF |
How gut immune cells can fight multiple sclerosis
Scientists are learning how our guts connect to our brains.
UCSF |
New multiple sclerosis drug that could halt disease meets FDA approval
Dr. Stephen Hauser achieves decades-long dream of turning science into therapy.
UC San Francisco |
Wrapping up multiple sclerosis at UCSF
With one drug to shut down its progression and another to undo its damage, MS doesn’t stand a chance.
UC Office of the President |
Proof of Concept grants
Proof of Concept grants move research to market.